Characterization of the immune related lncRNAs in bladder cancer to aid immunotherapy

Bladder cancer (BLCA) is the 10th most common form of cancer worldwide. Currently, the response rate of BLCA patients to novel immunotherapy and immune checkpoint inhibitor (ICI) treatment is around 30% or less. Therefore, there is an urgent clinical demand to understand the regulation of immune fun...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Ying, Dong, Yipeng, Yu, Tiannan, Wang, Rujie, Gao, Yang, Li, Song, Nong, Shaojun, Li, Wenguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462669/
https://www.ncbi.nlm.nih.gov/pubmed/36091015
http://dx.doi.org/10.3389/fimmu.2022.941189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462669/
https://www.ncbi.nlm.nih.gov/pubmed/36091015
http://dx.doi.org/10.3389/fimmu.2022.941189

Ejemplares similares